
Rush to restrict medicinal cannabis could cause additional harms, Penington Institute warns
The Therapeutic Goods Administration is being urged to maintain a balanced and evidence-based approach to medicinal cannabis access – or risk driving people to the unregulated illicit market. Amid rising concerns about patient safety in the medicinal cannabis sector, the TGA is reviewing medicinal cannabis regulations to ensure appropriate regulatory oversight